Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2013; 19(5): 742-749
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.742
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.742
Figure 3 Representative flow plots and level of CD4+CD25+Foxp3+T cell.
A: The normal group; B: The model group; C: The bifico group; D: The mesalazine group; E: The level of CD4+CD25+Foxp3+T. Normal: In the normal group, the animals were administrated with physiological saline; Model: In the model group, the animals were challenged with 2,4,6-trinitrobenzene sulfonic acid (TNBS) without treatment; Bifico: In the Bifico group, the animals were challenged by TNBS and treated with Bifico at 345 mg/kg; Mesalazine: In the Mesalazine group, the animals were challenged by TNBS and treated with 300 mg/kg Mesalazine. Data are means ± SE (n = 10). aP < 0.05 vs the normal group; cP < 0.05 vs the model group.
- Citation: Zhao HM, Huang XY, Zuo ZQ, Pan QH, Ao MY, Zhou F, Liu HN, Liu ZY, Liu DY. Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice. World J Gastroenterol 2013; 19(5): 742-749
- URL: https://www.wjgnet.com/1007-9327/full/v19/i5/742.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i5.742